Mosaic Immunoengineering Stock Current Valuation
| CPMV Stock | USD 0.61 0.39 39.00% |
Valuation analysis of Mosaic Immunoengineering helps investors to measure Mosaic Immunoengineerin's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Mosaic Immunoengineerin's price fluctuation is out of control at this time. Calculation of the real value of Mosaic Immunoengineering is based on 3 months time horizon. Increasing Mosaic Immunoengineerin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mosaic otc stock is determined by what a typical buyer is willing to pay for full or partial control of Mosaic Immunoengineering. Since Mosaic Immunoengineerin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mosaic OTC Stock. However, Mosaic Immunoengineerin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.61 | Real 0.6 | Hype 0.61 | Naive 0.59 |
The intrinsic value of Mosaic Immunoengineerin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mosaic Immunoengineerin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mosaic Immunoengineering helps investors to forecast how Mosaic otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mosaic Immunoengineerin more accurately as focusing exclusively on Mosaic Immunoengineerin's fundamentals will not take into account other important factors: Mosaic Immunoengineering OTC Stock Current Valuation Analysis
Mosaic Immunoengineerin's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Mosaic Immunoengineerin Current Valuation | 10.22 M |
Most of Mosaic Immunoengineerin's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mosaic Immunoengineering is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Mosaic Immunoengineering has a Current Valuation of 10.22 M. This is 99.93% lower than that of the Healthcare sector and 99.78% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Mosaic Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mosaic Immunoengineerin's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mosaic Immunoengineerin could also be used in its relative valuation, which is a method of valuing Mosaic Immunoengineerin by comparing valuation metrics of similar companies.Mosaic Immunoengineerin is currently under evaluation in current valuation category among its peers.
Mosaic Fundamentals
| Return On Asset | -4.2 | |||
| Current Valuation | 10.22 M | |||
| Shares Outstanding | 7.24 M | |||
| Shares Owned By Insiders | 88.73 % | |||
| Price To Book | 9.33 X | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.68 M) | |||
| Cash And Equivalents | 205.99 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 735.15 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.60) X | |||
| Cash Flow From Operations | (679.24 K) | |||
| Earnings Per Share | (0.51) X | |||
| Beta | -1.79 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 269.49 K | |||
| Z Score | -38.1 | |||
| Net Asset | 269.49 K |
About Mosaic Immunoengineerin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mosaic Immunoengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mosaic Immunoengineerin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mosaic Immunoengineering based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.